Albany Molecular Research (AMRI)
Add to Watchlists Create an AlertAlbany Molecular Research Liabilities:
56.42M for March 31, 2013Albany Molecular Research Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 56.42M |
| Dec. 31, 2012 | 56.72M |
| Sept. 30, 2012 | 59.91M |
| June 30, 2012 | 62.38M |
| March 31, 2012 | 58.02M |
| Dec. 31, 2011 | 56.63M |
| Sept. 30, 2011 | 60.33M |
| June 30, 2011 | 65.05M |
| March 31, 2011 | 74.35M |
| Dec. 31, 2010 | 81.36M |
| Sept. 30, 2010 | 75.57M |
| June 30, 2010 | 70.30M |
| March 31, 2010 | 60.12M |
| Dec. 31, 2009 | 59.08M |
| Sept. 30, 2009 | 66.79M |
| June 30, 2009 | 68.06M |
| March 31, 2009 | 73.48M |
| Dec. 31, 2008 | 64.00M |
| Sept. 30, 2008 | 58.38M |
| June 30, 2008 | 58.47M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
AMRI Liabilities Benchmarks
| Companies | |
|---|---|
| Cambrex Corporation | 238.79M |
| Achillion Pharmaceuticals | 10.84M |
| Anacor Pharmaceuticals | 46.26M |
AMRI Liabilities Rankings
| Overall |
77th percentile 1783 of 8006 |
| Sector |
44th percentile 380 of 686 in Healthcare |
| Industry |
35th percentile 159 of 248 in Biotechnology |
AMRI Liabilities Range, Past 5 Years
| Minimum | 56.42M | Mar 2013 |
| Maximum | 81.36M | Dec 2010 |
| Average | 64.27M |
AMRI News
Seeking Alpha May 22
